Information Library
Results for: Clinical Monitoring - Asia
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
Energizing Enrollment
Case Study — October 4, 2011
The rapid recruitment for this Phase III, open, randomized, controlled, multi-center study in adjuvant triple-negative breast cancer (TNBC) was completed two months earlier than planned. -
Model-Based Drug Development
Brochure — October 4, 2011
Our industry-leading model-based drug development services boost the probability of success in the New Health by enabling you to make critical decisions earlier, optimizing your resources and returns. -
Polish Pharmaceutical and Healthcare Sector
Media Coverage — September 9, 2011
To say ‘Sleeping Giant’ about Poland is no longer true claims Wojciech Przybys, VP EMEA and provides a deeper analysis of the polish clinical research -
KoNECT & Quintiles Partner to Advance Clinical Research
Press Release — May 30, 2011 – The Korea National Enterprise for Clinical Trials (KoNECT) and Quintiles have partnered to produce educational events in South Korea for investigators and biopharmaceutical companies.
-
Asia-Pacific Expertise
Case Study — May 11, 2011
Quintiles' experience and flexibility to understand cultural and communication differences across Asia Pacific provided an integrated solution which exceeded recruitment targets. -
Constant Vigilance
Case Study — March 16, 2011
Centralized planning played a key role in improving productivity during site visits and close monitoring ensured the high standards Quintiles put in place were met. -
Parkinson's Disease - Ambitious Recruitment
Case Study — February 1, 2011
Quintiles provided project management, clinical monitoring, and more for a study of a drug for patients with early stage idiopathic Parkinson’s disease. -
Global Response HIV
Case Study — February 1, 2011
Due to its global reach and extensive experience, Quintiles successfully managed 830 sites in 32 countries and recruited 14,521 patients. -
A Lock on Consistency
Case Study — February 1, 2011
A double-blind, randomized, placebo-controlled trial evaluating the safety and efficacy of eplerenone in patients with heart failure following acute myocardial infarction. -
Acute Coronary Syndrome - Tailored Solutions
Case Study — February 1, 2011
Find out how our experience in multi-national cardiovascular clinical trials helped this customer reach database lock 66 days after LPO.